Michael Green
Michael Green
Verified email at ucla.edu
Title
Cited by
Cited by
Year
What are the functional consequences of neurocognitive deficits in schizophrenia?
MF Green
The American journal of psychiatry, 1996
44591996
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?
MF Green, RS Kern, DL Braff, J Mintz
Schizophrenia bulletin 26 (1), 119-136, 2000
35672000
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
KH Nuechterlein, MF Green, RS Kern, LE Baade, DM Barch, JD Cohen, ...
American Journal of Psychiatry 165 (2), 203-213, 2008
18772008
Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS
MF Green, RS Kern, RK Heaton
Schizophrenia research 72 (1), 41-51, 2004
16102004
Identification of separable cognitive factors in schizophrenia
KH Nuechterlein, DM Barch, JM Gold, TE Goldberg, MF Green, ...
Schizophrenia research 72 (1), 29-39, 2004
14192004
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
RSE Keefe, RM Bilder, SM Davis, PD Harvey, BW Palmer, JM Gold, ...
Archives of general psychiatry 64 (6), 633-647, 2007
12152007
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
MF Green, KH Nuechterlein, JM Gold, DM Barch, J Cohen, S Essock, ...
Biological psychiatry 56 (5), 301-307, 2004
9792004
Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities
MF Green, DL Penn, R Bentall, WT Carpenter, W Gaebel, RC Gur, ...
Schizophrenia bulletin 34 (6), 1211-1220, 2008
9582008
Training and quality assurance with the Brief Psychiatric Rating Scale:" the drift busters."
J Ventura, MF Green, A Shaner, RP Liberman
International Journal of Methods in Psychiatric Research, 1993
9551993
Cognitive impairment and functional outcome in schizophrenia and bipolar disorder
MF Green
Journal of Clinical Psychiatry 67, 3, 2006
8922006
Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure
DE Gard, AM Kring, MG Gard, WP Horan, MF Green
Schizophrenia research 93 (1-3), 253-260, 2007
7842007
Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P)
J Ventura, RP Liberman, MF Green, A Shaner, J Mintz
Psychiatry research 79 (2), 163-173, 1998
6831998
Should schizophrenia be treated as a neurocognitive disorder?
MF Green, KH Nuechterlein
Schizophrenia bulletin 25 (2), 309-319, 1999
6721999
Social cognition in schizophrenia
MF Green, WP Horan, J Lee
Nature Reviews Neuroscience 16 (10), 620-631, 2015
6632015
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization
RS Kern, KH Nuechterlein, MF Green, LE Baade, WS Fenton, JM Gold, ...
American Journal of Psychiatry 165 (2), 214-220, 2008
6242008
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
MF Green, BD Marshall Jr, WC Wirshing, D Ames, SR Marder, S McGurk, ...
American Journal of Psychiatry 154 (6), 799-804, 1997
5961997
Biosocial pathways to functional outcome in schizophrenia
J Brekke, DD Kay, KS Lee, MF Green
Schizophrenia research 80 (2-3), 213-225, 2005
5402005
Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference
MF Green, B Olivier, JN Crawley, DL Penn, S Silverstein
Schizophrenia bulletin 31 (4), 882-887, 2005
5352005
Baseline neurocognitive deficits in the CATIE schizophrenia trial
RSE Keefe, RM Bilder, PD Harvey, SM Davis, BW Palmer, JM Gold, ...
Neuropsychopharmacology 31 (9), 2033-2046, 2006
5292006
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia
RW Buchanan, M Davis, D Goff, MF Green, RSE Keefe, AC Leon, ...
Schizophrenia bulletin 31 (1), 5-19, 2005
5242005
The system can't perform the operation now. Try again later.
Articles 1–20